195
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Prevalence of Inflammatory Bowel Disease in Norway and the Impact of Different Case Definitions: A Nationwide Registry Study

ORCID Icon, , , &
Pages 287-294 | Published online: 23 Apr 2021

References

  • Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–337. doi:10.1016/j.crohns.2013.01.01023395397
  • Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. doi:10.1053/j.gastro.2011.10.00122001864
  • Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–321.e2. doi:10.1053/j.gastro.2016.10.02027793607
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-029050646
  • Henriksen M, Jahnsen J, Lygren I, et al. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41(9):1037–1043. doi:10.1080/0036552060055452716938716
  • Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Elsevier Enhanced Reader. Available from: https://reader.elsevier.com/reader/sd/pii/S1873994609001469?token=B0C6C12C79343D3D5603FCBEB44707A86E24DAFB0A5F2A056EE7984ED051BD5606143C94402E03A01FBEFD7009D96DAF. Accessed 220, 2020.
  • Norwegian Institute of Public Health. The Norwegian Prescription Database 2012–2016; 2017. Available from: https://www.fhi.no/contentassets/10528e05afc141408bc8a8fb5dfb7109/reseptregisteret-2012-2016.pdf. Accessed 412, 2021.
  • Büsch K, Ludvigsson JF, Ekström‐Smedby K, Ekbom A, Askling J, Neovius M. Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study. Aliment Pharmacol Ther. 2014;39(1):57–68. doi:10.1111/apt.1252824127738
  • Lophaven SN, Lynge E, Burisch J. The incidence of inflammatory bowel disease in Denmark 1980–2013: a nationwide cohort study. Aliment Pharmacol Ther. 2017;45(7):961–972. doi:10.1111/apt.1397128229470
  • Everhov ÅH, Halfvarson J, Myrelid P, et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology. 2018;154(3):518–528.e15. doi:10.1053/j.gastro.2017.10.03429102619
  • Jakobsson GL, Sternegård E, Olén O, et al. Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216–221. doi:10.1080/00365521.2016.124660527797278
  • Bengtson M-B, Solberg C, Aamodt G, et al. Familial aggregation in Crohn’s disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years. J Crohns Colitis. 2009;3(2):92–99. doi:10.1016/j.crohns.2008.11.00221172251
  • Moum B, Vain MH, Ekbom A, et al. Incidence of inflammatory bowel disease in Southeastern Norway: evaluation of methods after 1 year of registration. DIG. 1995;56(5):377–381. doi:10.1159/000201262
  • Benchimol EI, Guttmann A, Mack DR, et al. Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. J Clin Epidemiol. 2014;67(8):887–896. doi:10.1016/j.jclinepi.2014.02.01924774473